Stocks and Investing Stocks and Investing
Wed, December 18, 2019
Tue, December 17, 2019

David Lewis Maintained (ZBH) at Buy with Increased Target to $170 on, Dec 17th, 2019


Published on 2024-10-26 19:15:37 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Increased Target from $150 to $170 on, Dec 17th, 2019.

David has made no other calls on ZBH in the last 4 months.



There are 6 other peers that have a rating on ZBH. Out of the 6 peers that are also analyzing ZBH, 0 agree with David's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with David


  • Lawrence Keusch of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $170 on, Wednesday, December 4th, 2019
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $165 on, Wednesday, November 6th, 2019
  • Shagun Singh of "RBC Capital" Maintained at Buy with Increased Target to $155 on, Wednesday, November 6th, 2019
  • Ryan Zimmerman of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $158 on, Monday, October 7th, 2019
  • Kyle Rose of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Increased Target to $167 on, Wednesday, September 18th, 2019
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $158 on, Monday, September 9th, 2019
Contributing Sources